Zander E, de Tribolet N, Wagenknecht L
Acta Neurochir (Wien). 1978;42(1-2):97-101. doi: 10.1007/BF01406635.
The preliminary results of a combined chemotherapy trial with VM 26 and BCNU for recurrent malignant gliomas are presented. Four patients out of seven responded favourably to this treatment. Toxicity was mild and reversible.
本文介绍了VM 26和卡氮芥联合化疗复发性恶性胶质瘤的初步结果。7例患者中有4例对此治疗反应良好。毒性轻微且可逆。